Medical Device | October 28, 2021
Thermo Fisher Scientific unveils Q Digital PCR system
It is the first integrated digital PCR solution ideal for oncology, cell and gene therapy development
It is the first integrated digital PCR solution ideal for oncology, cell and gene therapy development
It’s the company’s fourth manufacturing site worldwide. Others are located in the US, UK and China
This expansion will support the global operations network and help meet global demand for mammalian development services that support Lonza’s manufacturing sites
The clinical trial, to be conducted in two phases, will evaluate the safety and efficacy of Mesocel for the treatment of patients with moderate to severe Covid-19
Asia-Pacific is projected to portray the fastest CAGR of 13.2 by 2030
A veteran in cell therapy and oncology commercialisation
It leverages Kite’s Chimeric Antigen Receptors and Appia Bio’s Allogeneic Cell Technology Platform to Develop Off-the-Shelf Cell Therapies
Subscribe To Our Newsletter & Stay Updated
